ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER announces public meeting on atrial fibrillation management options appraisal for July 2010 |
|
ICER has scheduled an Evidence Review Group meeting to review and discuss its findings on the comparative clinical effectiveness and comparative value of selected technologies and medications for atrial fibrillation. These meetings are open to the public. Meeting details can be found below:
Atrial Fibrillation Management Options
Date: July 16, 2010
Time: 10:00 am – 3:30 pm
Location: Richard B. Simches Research Center, Massachusetts General Hospital
185 Cambridge St.
Boston, MA 02114
Conference Room 3130
Please contact
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
if you would like to attend or if you have any questions. |